RCM
COCH icon

Radcliffe Capital Management’s Envoy Medical COCH Stock Holding History

Radcliffe Capital Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-582,364
Closed -$5.84M – 699
2022
Q4 		$5.84M Hold
582,364
– – 0.18% 162
2022
Q3 		$5.72M Buy
582,364
+82,364
+16% +$809K 0.14% 227
2022
Q2 		$4.9M Hold
500,000
– – 0.11% 291
2022
Q1 		$4.88M Hold
500,000
– – 0.11% 263
2021
Q4 		$4.87M Hold
500,000
– – 0.13% 198
2021
Q3 		$4.86M Hold
500,000
– – 0.14% 174
2021
Q2 		$4.87M Buy
+500,000
New +$4.86M 0.15% 166

Other funds holding COCH

AMC
Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Radcliffe Capital Management's COCH Position: Q1 2023 in Review

Radcliffe Capital Management sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 582,364 shares — an estimated $5.84M sold.

Radcliffe Capital Management first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $5.84M in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • Radcliffe Capital Management reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 582,364 Envoy Medical shares in Q1 2023, an estimated $5.84M.
  • Radcliffe Capital Management first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • Radcliffe Capital Management's Envoy Medical position peaked at $5.84M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.